openPR Logo
Press release

Uterine Fibroids Treatment Market | Technological breakthroughs, Value chain and stakeholder analysis by 2024

09-07-2017 10:00 PM CET | Health & Medicine

Press release from: Transparency Market Research

Uterine Fibroids Treatment Market | Technological

The U.S. Uterine Fibroids Market shows a strong presence of players. The top three players in the market are Boston Scientific Corporation, Smith & Nephew, and Hologic, Inc., who hold a share of nearly 50% in the overall market. The players are focused mergers and acquisitions to broaden their product portfolio and integration of knowledge base. To remain dominant players are anticipated to lay emphasis on product differentiation. The report published by Transparency Market Research states that the U.S. uterine fibroid treatment market was valued at US$211.6 mn in 2015 and is expected to be worth US$273.6 mn by the end of 2024. During the forecast years of 2016 and 2024, the overall market is anticipated to progress at a CAGR of 2.9%.

View Report-

http://www.transparencymarketresearch.com/us-uterine-fibroid-treatment-market.html

Hysterectomy Segment to Lead Global Market

Out of all the procedures, the hysterectomy segment is showing a promise of good growth rate in the near future. This segment is projected to account for a share of 79.6% by the end of 2016. The benefits of hysterectomy such as alleviation of pelvic pain, excessive menstrual bleeding, and physical morbidity are driving this segment. Furthermore, hospitals will emerge as the leading end users of uterine fibroid treatment options in the coming years. By the end of 2016, the hospitals segment is projected to account for a share of 67.1% in the U.S. uterine fibroids treatment market.

Technological Advancements in Minimally Invasive Surgeries Augurs Well for Market

The introduction of a minimally invasive surgeries to treat the excruciatingly painful uterine fibroids is expected boost the market’s growth in the coming years. “Advantages of such procedures such as minimal recovery time, reduced chances of infections, and shorter hospital stays are also encouraging patients and hospitals to choose these treatments,” states the lead author of this research report. The market is also benefitting from the regulatory approvals being granted to newer types of treatment and surgeries. Thus, the introduction of newer technologies that offer efficient results is creating a positive influence on the U.S. uterine fibroids market. The remarkable changes in technology have also played their supportive part in the growth of the market over the past few years. For instance, Halt Medical, Inc. introduced Acessa Guidance System in 2016. This technology enhances the radiofrequency ablation and electromagnetic tracking technology to treat uterine myomas laparoscopically.

The supportive reimbursement policies are also expected to augment the demand for uterine fibroids treatment in the near future. Favorable policies are helping the patients to cover their expenses in hospitals as well the ones incurred in ambulatory surgical centers. Statistics state that there are 20% to 40% chances of development of uterine fibroids in women around the age of 35. Thus, the high prevalence of uterine fibroids amongst women in the reproductive age bracket has become the very basis of the growth of this market. Furthermore, African American women are more likely to develop fibroids, which is also a key population base contributing to the steady rise in the revenue of the U.S. uterine fibroids market.

Request to download and view full ToC -

http://www.transparencymarketresearch.com/report-toc/16775

Possibility of Complications due to Procedures Tugs at Market in Opposite Direction

The uterine fibroids treatment market is likely to be hampered by the announcement made by the FDA that power morcellators can lead to complications such as spreading metastatic leiomyosarcoma cancer tissue. Availability of wide range of alternative treatments is also anticipated to hinder the market’s growth in the near future. The market is also being restrained by the possibility of urinary tract injury while performing minimally invasive procedures.

Request to view Sample Report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16775

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids Treatment Market | Technological breakthroughs, Value chain and stakeholder analysis by 2024 here

News-ID: 704348 • Views: 304

More Releases from Transparency Market Research

Voltage Detectors Market – Evolving Technology Trends and Industry SWOT Analys …
The global voltage detectors market includes large number of players. Some of the key players are Texas Instruments, Toshiba, ROHM Semiconductor Sharp Microelectronics, Analog Devices Inc., STMicroelectronics, ON Semiconductor, Torex Semiconductor, Taiwan Semiconductor and Seiko Instruments. Browse Our Report @ https://www.transparencymarketresearch.com/voltage-detectors-market.html Voltage Detector is a testing equipment generally used to determine the existence or absence of an electrical charge in an object. It is highly suggested for conditions where power issues exist.
Switched Capacitor Filters Market : Key Segments, Maket Insights, Regional Outlo …
Major players in the global switched capacitor filters market are Texas Instruments Incorporated, Analog Devices, Inc., Maxim Integrated, Inc., Siemens AG, Eaton Corporation, and among others. Browse Our Report @ https://www.transparencymarketresearch.com/switched-capacitor-filters-market.html A switched capacitor filter is an active filter based on the consideration that a switching of capacitors between two circuit nodes at an adequately high rate that is equivalent to a resistor connecting these two nodes. The switched capacitor filters are
Current Calibrator Market : Recent Industry Developments And Growth Strategies A …
Key players operating in the global current calibrator market include Valhalla Scientific, Rotek Inc., Time Electronics, PCE Instruments, Martel Electronics, AOIP Instrumentation, Extech Instruments, Yogokawa Test & Measurement Corporation, Extech Instruments, REED Instruments, Fluke Corporation, and others. These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the
Damp Meter Market – Outlook by Responsible Drivers, Restraints, Demand
Key players operating in the global damp meter market include PCE Instrument, Delmhorst Instrument Co., GENERAL TOOLS & INSTRUMENTS LLC, FLIR Systems, Inc. designs, Panomex Inc., These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the global market are collaborations, partnerships, agreements, and new product launches. The

All 5 Releases


More Releases for Uterine

Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape. Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers
Uterine Leiomyoma (Uterine Fibroids) Market: Global Industry Size, Share, Growth …
Latest industry research report on: Global Uterine Leiomyoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. DelveInsight's,Uterine Leiomyoma (Uterine Fibroids)-Global API Manufacturers,Marketed and Phase III Drugs Landscape,2018" report provides comprehensive insights about marketed and Phase III products for Uterine Leiomyoma (Uterine Fibroids) . The report includes information of marketed products including their product description,patent details,forecasted sales till 2020 & API manufacturer details by country. Global API
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017”. Uterine fibroids are benign tumors that originate in the uterus (womb). Although they are composed of the same smooth muscle fibers as the uterine wall (myometrium), they are much denser than normal myometrium. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246573 Uterine fibroids are usually round. The most common
Uterine Cancer Therapeutics market report by 2021
According to the report “Global Uterine Cancer Therapeutics Market", published by Market Data Forecast, the global market is projected to reach USD 22,686.3 million by 2021, at a CAGR of 5.45 % from 2016 to 2021. For full report refer to : http://www.marketdataforecast.com/market-reports/global-uterine-cancer-therapeutics-market-1489/ Uterine cancer is one of most commonly prevailing malignant tumours that starts in the cells of the uterus and spreads to other parts of the body. Uterine